Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04524455
Title A Study of Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Acute Lymphoblastic Leukemia (ALL)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen

acute lymphoblastic leukemia



AMG 404 + Blinatumomab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | AUT

No variant requirements are available.